Global Polyisoprene Surgical Gloves Market Strategic Research Report
By Type: Standard Type, Micro (ultra-thin), Orthopedic (thick)
By Application: Hospital, Clinic, Other
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: HARPS Holdings, Cardinal Health, Hartalega Holdings Berhad, Motex Healthcare Corp., WRP Asia Pacific Sdn. Bhd, Top Glove Corporation Bhd, HBM Protection, O&M Halyard, Ansell Limited, Mölnlycke Health Care AB, Sanko Kagaku Co., Ltd., Bimedica
概述
Scope of the Report
The global Polyisoprene Surgical Gloves market size is predicted to grow from US$ 243 million in 2025 to US$ 373 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.
In the medical industry, gloves are essential protective equipment for medical staff and play a vital role. They not only play a key role in surgical operations, but also effectively reduce the risk of bacterial infection and sharp punctures. When medical staff come into contact with patients, medical gloves are a strong guarantee for their safety, which can effectively isolate germs and prevent cross infection.
In recent years, the field of medical protection has ushered in a new type of medical gloves - polyisoprene surgical gloves, referred to as PI gloves. PI gloves use high-quality polyisoprene (PI) as raw material to create protective performance comparable to natural latex surgical gloves. It provides a solid guarantee for surgical operations, effectively protects the safety of patients and users, and helps reduce the risk of cross infection.
The current global market size of polyisoprene surgical gloves is relatively small, mainly dominated by a few raw material manufacturers such as Zeon and Cariflex and a few downstream high-end glove manufacturers. The price is much higher than natural latex and nitrile gloves, mainly meeting the needs of high-end hospitals and specific departments in developed regions such as Europe and the United States. Against the backdrop of the gradual implementation of domestic raw material localization and the continuous improvement of production processes, polyisoprene gloves are expected to break the dependence on imported raw materials and technologies, complete the localized supply closed loop, and accelerate entry into the high-end European and American markets through overseas registration and certification, realizing import substitution and value-added export dual-wheel drive. In response to trade barriers and geopolitical uncertainties, leading companies are accelerating the layout of production bases in Southeast Asia, Latin America and other places, while paying attention to the next generation of high-end latex-free protein materials similar to polyisoprene, such as functionalized synthetic latex, degradable biomaterials, etc., to maintain the dual leadership of material upgrades and cost optimization.
As the global medical industry continues to pay more attention to the risk of allergies to natural latex proteins, polyisoprene gloves have become the preferred alternative for many high-end specialties such as cardiac surgery and neurosurgery in scenarios where operation sensitivity is extremely high, thanks to their comfort and elasticity that are extremely similar to natural latex. They effectively fill the gap in comfort of traditional materials such as nitrile and chloroprene. The original positioning of polyisoprene surgical gloves was to meet the needs of high-end hospitals in developed countries for low-allergenicity and high-comfort specialty surgeries. This attribute determines its high price range, concentrated customer base and stable purchasing intention. In the post-epidemic era, the disposable protective glove industry has entered a stage of destocking and de-low-endization. Global hospitals and medical staff have relatively rigid budgets for hospital infection safety and are willing to pay for differentiated performance. The logic of polyisoprene's "high-end, low-sensitivity alternative" has become increasingly prominent.
This report presents a comprehensive overview of the global Polyisoprene Surgical Gloves market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Standard Type
- Micro (ultra-thin)
- Orthopedic (thick)
Segment by Size
- 6
- 6.5
- 7
- 7.5
- 8
- Other Size
Segment by Application
- Hospital
- Clinic
- Other
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Polyisoprene Surgical Gloves market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Hospital, Clinic, Other evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Polyisoprene Surgical Gloves Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Standard Type
- 3.1.3 Micro (ultra-thin)
- 3.1.4 Orthopedic (thick)
- 3.1.5 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Hospital
- 4.1.3 Clinic
- 4.1.4 Other
- 4.1.5 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 HARPS Holdings
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Cardinal Health
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Hartalega Holdings Berhad
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Motex Healthcare Corp.
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 WRP Asia Pacific Sdn. Bhd
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Top Glove Corporation Bhd
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 HBM Protection
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 O&M Halyard
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Ansell Limited
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Mölnlycke Health Care AB
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Sanko Kagaku Co., Ltd.
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Bimedica
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the size of the global Polyisoprene Surgical Gloves market?
What is the forecast CAGR for the Polyisoprene Surgical Gloves market?
What is Polyisoprene Surgical Gloves?
What are the main segments of the Polyisoprene Surgical Gloves market by type?
Which applications drive demand in the Polyisoprene Surgical Gloves market?
Who are the key players in the Polyisoprene Surgical Gloves market?
Which regions and countries are covered for Polyisoprene Surgical Gloves?
Who should buy the Polyisoprene Surgical Gloves market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Polyisoprene Surgical Gloves Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices